Home » Topics » Regulatory » Patents

Patents
RSS

New prodrug approach claimed by Merck & Co.

Dec. 23, 1997

New antiviral agent for flu disclosed in patent literature

Dec. 22, 1997

HGS discloses new cysteine protease inhibitor

Dec. 22, 1997

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

Dec. 22, 1997

Farnesyltransferase inhibitors lacking a thiol moiety from Merck & Co.

Dec. 19, 1997

Protein MOT12 for diagnosis of IDDM

Dec. 19, 1997

Bayer develops compounds for neurodegenerative disorders

Dec. 19, 1997

Boehringer Mannheim describes antiplatelet agents

Dec. 18, 1997

Several series of integrin antagonists prepared at Searle

Dec. 18, 1997

Antidiabetic agents under development at Takeda

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.